Large US Employers Shunning HMOs

4 November 1996

Some large employers in Minnesota are complaining that health maintenance organizations, which they had supported as a way to cut their medical costs, have now grown so big that they are stifling competition and medical innovation. From January 1, these firms, including General Mills, Honeywell, Pillsbury and American Express, will begin buying medical services for 400,000 people directly from organized groups of doctors, hospitals and clinics.

Under the plan, about 15 groups of doctors, hospitals and clinics comprising over 90% of primary care doctors and specialists in the Minneapolis-St Paul area will provide a standard package of benefits and comparative information on cost, medical quality and customer service. Employees will get vouchers to buy medical coverage from any one of the groups, whose services will differ in price.

A spokesman for the employers' coalition, the 24-member Buyers' Health Care Action Group, says this will encourage employees to shop around for health care by comparing price, quality and service.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight